Navigating Heart Failure Treatments

This chapter focuses on the medication vericiguat and its role in managing heart failure, particularly in the context of the Victoria trial outcomes. It emphasizes the importance of optimizing guideline-directed medical therapy (GDMT) before considering advanced interventions, and discusses patient selection in relation to secondary mitral regurgitation. The chapter also highlights critical indicators for when heart failure patients should seek specialist care, underscoring the need for personalized treatment strategies.